IBERE PHARMACEUTICALS

Serial Number 90557662
732

Registration Progress

Application Filed
Mar 3, 2021
Under Examination
Jul 28, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Trademark Image

IBERE PHARMACEUTICALS

Basic Information

Serial Number
90557662
Filing Date
March 3, 2021
Published for Opposition
May 31, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
May 24, 2024
Application
Pending
Classes
005

Rights Holder

IBERE PHARMACEUTICALS, LLC

16
Address
2005 MARKET STREET
SUITE 2030
PHILADELPHIA, PA 19103

Ownership History

Ibere Pharmaceuticals

Original Applicant
99
Philadelphia, PA

Ibere Pharmaceuticals

Owner at Publication
99
Philadelphia, PA

IBERE PHARMACEUTICALS, LLC

New Owner After Publication #1
16
PHILADELPHIA, PA

Legal Representation

Attorney
Clarissa Marischen

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
May 28, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 25, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 25, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 24, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 20, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 26, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 3, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2022 NEWN I NEW NOA TO ISSUE Loading...
Jul 28, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 26, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 25, 2022 ALIE A ASSIGNED TO LIE Loading...
Apr 22, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 25, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
house mark for a full line of pharmaceuticals

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"